Biotech China 2014

Oncology: Weill Cornell Medical College

Total Score People Score Events Score
31 22 17
Date Event Presentation Speakers
May 31, 2013 ASCO Annual Meeting 2013 Education Sessions Andrew J. Dannenberg
Special Session Larry Norton
April 6, 2013 AACR Annual Meetings Obesity, Energy Balance, and Metabolism Chairperson: Eileen P. White, UMDNJ-The Cancer Institute of New Jersey, New Brunswick, NJ Andrew J. Dannenberg
Myeloid Malignancies Co-Chairpersons: Ari M. Melnick, Weill Cornell Medical College of Cornell University, New York, NY, and Timothy Graubert, Washington University School of Medicine, St. Louis, MO Ari M. Melnick
Targeting Lymphoid Malignancies: Working from the Outside In Co-Chairpersons: John P. Leonard, Weill Cornell Medical Center, New York, NY, and John C. Byrd, The Ohio State University Comprehensive Cancer Center, Columbus, OH John P. Leonard
Central Role of the Mircroenvironment in Initiation and Progression of Tumors and Response to Chemotherapy Chairperson: Mina J. Bissell, Lawrence Berkeley National Laboratory, Berkeley, CA Shahin Rafii, Larry Norton
Nuclear Topology and Transcription Factors: Defining the Architecture of Normal and Malignant Cells Chairperson: Ari M. Melnick, Weill Cornell Medical College of Cornell University, New York, NY Ari M. Melnick
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY David C Lyden
September 13, 2012 International Society of Gastrointestinal Oncology Hepatocellular Carcinoma: Novel Molecular Approaches for Diagnosis, Prognosis and Therapy Ghassan K Abou-Alfa
August 3, 2011 21st Annual Mayo Clinic Hematology/Oncology Reviews Management of Localized Esophageal and GEJ Cancers David H. Ilson
December 10, 2010 Preventive Care and Integrative Medicine: Focus on Oncology and New Strategies in Preventive Medicine Cancer Survivorship Challenges and Opportunities Mitchell L. Gaynor
April 9, 2010 Duke Debates: Controversies in the Management of Patients With Hematologic Malignancies Case-Based Presentation Myeloproliferative Neoplasms: What Are We All JAKed Up About? Richard T. Silver
October 2, 2009 13th Annual Fall Oncology Conference: Clinical Challenges in Cancer Medicine State-of-the-Art Therapy for TCL John P. Leonard
October 1, 2009 6TH ANNUAL MEETING OF THE INTERNATIONAL SOCIETY OF GASTROINTESTINAL ONCOLOGY (ISGIO) Increasing Importance of Esophageal Cancer: Epidemiology and Combined Modality Approaches David H. Ilson
July 22, 2009 Eighth International Congress on the Future of Breast Cancer Hormone-Responsive Breast Cancer Anne Moore
January 28, 2009 Clinical Trials for Special Populations Utilising biomarkers to identify the population with benefit David Wilson
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) Biopharmaceuticals in Plants; Toward the Next Century of Medicine:Track 2-3 K. L., Hefferon
Session Chair :Track 4-1 (II) K. L., Hefferon
Biopharmaceuticals in plants; toward the next century of medicine :Track 4-1 (II) K. L., Hefferon
Bioengineered Crops as Tools for International Development: Opportunities and Strategic Considerations : Track 4-4 PETER GREGORY
November 26, 2008 Speed and Safety in Drug Discovery Hurel, an in vivo surrogate assay platform for cell-based studies Gregory Baxter
November 6, 2008 The 2008 Research Conference on Food, Nutrition, Physical Activity & Cancer Split Session B: Introduction Richard S. Rivlin
Overview: Probiotics and Cancer Susanna Cunningham-Rundles
May 30, 2008 ASCO Annual'08 Meeting professional development-- Maintenance of Certification and Lifelong Learning Workshop Joseph T. Ruggiero
professional development-- Teaching the Teacher: Keys to Speaker Success Larry Norton
March 25, 2008 PATHWAY ANALYSIS Biochemical Pathway Databases for Plants Lukas Mueller
November 6, 2007 Chemotherapy Foundation Symposium XXV NOVEL THERAPEUTICS IN AML Gail J Roboz
LENALIDOMIDE IN MDS: UPDATE ON NON DEL 5Q PATIENTS Gail J Roboz
RITUXIMAB COMBINATIONS IN NHL John P. Leonard
DOES BEVACIZUMAB WORK EQUALLY WELL WITH ALL CHEMOTHERAPY DRUGS? CONFLICTING VIEWS Leonard B. Saltz
ADVANCES IN THE TREATMENT OF ESOPHAGOGASTRIC CANCER David H. Ilson
RATIONAL DESIGN OF DOSE AND SCHEDULE OF Larry Norton
Dinner & Special Presentations Educational Grant: Bayer HealthCare/Onyx Pharmaceuticals Ghassan K Abou-Alfa
October 20, 2007 Fourth Annual Fall Oncology Conference Esophageal and Gastric Cancer: Are We Making Progress? David H. Ilson
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.